BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 36894134)

  • 1. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
    Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
    Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The battle of lipid-based nanocarriers against blood-brain barrier: a critical review.
    Abla KK; Mehanna MM
    J Drug Target; 2023 Sep; 31(8):832-857. PubMed ID: 37577919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.
    Bachu RD; Chowdhury P; Al-Saedi ZHF; Karla PK; Boddu SHS
    Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29495528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to the eye: what benefits do nanocarriers offer?
    Joseph RR; Venkatraman SS
    Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
    Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
    Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
    Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers for ocular drug delivery: Recent advances and future opportunities.
    Amrutkar CS; Patil SB
    Indian J Ophthalmol; 2023 Jun; 71(6):2355-2366. PubMed ID: 37322644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of organic nanocarriers for intraocular drug delivery.
    Chang W; Shen J; Liu Z; Chen Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):259-266. PubMed ID: 37476937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
    Yang M; Gu Y; Tang X; Wang T; Liu J
    Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.
    Harshita ; Barkat MA; Das SS; Pottoo FH; Beg S; Rahman Z
    Curr Pharm Des; 2020; 26(11):1167-1180. PubMed ID: 32026769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of nanoparticles in ophthalmology.
    Diebold Y; Calonge M
    Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
    Jacob S; Nair AB; Shah J; Gupta S; Boddu SHS; Sreeharsha N; Joseph A; Shinu P; Morsy MA
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.